These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21845143)

  • 21. Should oral misoprostol be used to prevent postpartum haemorrhage in home-birth settings in low-resource countries? A systematic review of the evidence.
    Hundley VA; Avan BI; Sullivan CJ; Graham WJ
    BJOG; 2013 Feb; 120(3):277-85; discussion 86-7. PubMed ID: 23190345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.
    Atukunda EC; Siedner MJ; Obua C; Mugyenyi GR; Twagirumukiza M; Agaba AG
    PLoS Med; 2014 Nov; 11(11):e1001752. PubMed ID: 25369200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interpretation of national policy regarding community-based use of misoprostol for postpartum hemorrhage prevention in Ethiopia: a tale of two regions.
    Spangler SA; Gobezayehu AG; Hailemariam TG; Sibley LM
    J Midwifery Womens Health; 2014 Jan; 59 Suppl 1():S83-90. PubMed ID: 24588920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initiating a novel therapy in preventing postpartum hemorrhage in rural India: a joint collaboration between the United States and India.
    Kodkany BS; Derman RJ; Goudar SS; Geller SE; Edlavitch SA; Naik VA; Patel A; Bellad MB; Patted SS
    Int J Fertil Womens Med; 2004; 49(2):91-6. PubMed ID: 15188836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perceptions and experiences of the prevention, detection, and management of postpartum haemorrhage: a qualitative evidence synthesis.
    Akter S; Forbes G; Vazquez Corona M; Miller S; Althabe F; Coomarasamy A; Gallos ID; Oladapo OT; Vogel JP; Lorencatto F; Bohren MA
    Cochrane Database Syst Rev; 2023 Nov; 11(11):CD013795. PubMed ID: 38009552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster-randomised non-inferiority community trial.
    Raghavan S; Geller S; Miller S; Goudar SS; Anger H; Yadavannavar MC; Dabash R; Bidri SR; Gudadinni MR; Udgiri R; Koch AR; Bellad MB; Winikoff B
    BJOG; 2016 Jan; 123(1):120-7. PubMed ID: 26333044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Misoprostol for preventing and treating postpartum hemorrhage in the community: a closer look at the evidence.
    Oladapo OT
    Int J Gynaecol Obstet; 2012 Nov; 119(2):105-10. PubMed ID: 22968139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial.
    Mobeen N; Durocher J; Zuberi N; Jahan N; Blum J; Wasim S; Walraven G; Hatcher J
    BJOG; 2011 Feb; 118(3):353-61. PubMed ID: 21176086
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advance distribution of misoprostol for the prevention of postpartum hemorrhage in South Sudan.
    Smith JM; Dimiti A; Dwivedi V; Ochieng I; Dalaka M; Currie S; Luka EE; Rumunu J; Orero S; Mungia J; McKaig C
    Int J Gynaecol Obstet; 2014 Nov; 127(2):183-8. PubMed ID: 25051905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Misoprostol for Prevention of Postpartum Hemorrhage at Home Birth in Afghanistan: Program Expansion Experience.
    Haver J; Ansari N; Zainullah P; Kim YM; Tappis H
    J Midwifery Womens Health; 2016; 61(2):196-202. PubMed ID: 26849472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postpartum hemorrhage prevention in Nepal: a program assessment.
    Rajbhandari SP; Aryal K; Sheldon WR; Ban B; Upreti SR; Regmi K; Aryal S; Winikoff B
    BMC Pregnancy Childbirth; 2017 Jun; 17(1):169. PubMed ID: 28583092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perceptions and management of postpartum haemorrhage among remote communities in Lao PDR.
    Hose I; Durham J; Phengsavanh A; Sychareun V; Vongxay V; Xaysomphou D; Rickart K
    Rural Remote Health; 2020 Jan; 20(1):5436. PubMed ID: 31918553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knowledge, acceptability, and use of misoprostol for preventing postpartum hemorrhage following home births in rural Ethiopia.
    Gebre B; Taddese Z; Deribe K; Legesse T; Omar M; Biadgilign S
    Int J Gynaecol Obstet; 2016 Jul; 134(1):79-82. PubMed ID: 27090217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A regional comparison of distribution strategies and women's awareness, receipt, and use of misoprostol to prevent postpartum hemorrhage in rural Amhara and Oromiya regions of Ethiopia.
    Sibley LM; Spangler SA; Barry D; Tesfaye S; Desta BF; Gobezayehu AG
    J Midwifery Womens Health; 2014 Jan; 59 Suppl 1():S73-82. PubMed ID: 24588919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxytocin via Uniject (a prefilled single-use injection) versus oral misoprostol for prevention of postpartum haemorrhage at the community level: a cluster-randomised controlled trial.
    Diop A; Daff B; Sow M; Blum J; Diagne M; Sloan NL; Winikoff B
    Lancet Glob Health; 2016 Jan; 4(1):e37-44. PubMed ID: 26718808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage - Do Costs Matter?
    Chatterjee S; Sarkar A; Rao KD
    PLoS One; 2016; 11(10):e0164718. PubMed ID: 27755601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postpartum misoprostol for preventing maternal mortality and morbidity.
    Hofmeyr GJ; Gülmezoglu AM; Novikova N; Lawrie TA
    Cochrane Database Syst Rev; 2013 Jul; (7):CD008982. PubMed ID: 23857523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial.
    Walraven G; Blum J; Dampha Y; Sowe M; Morison L; Winikoff B; Sloan N
    BJOG; 2005 Sep; 112(9):1277-83. PubMed ID: 16101608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of postpartum haemorrhage: cost consequences analysis of misoprostol in low-resource settings.
    Lang DL; Zhao FL; Robertson J
    BMC Pregnancy Childbirth; 2015 Nov; 15():305. PubMed ID: 26596797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind, randomized controlled trial to explore oral tranexamic acid as adjunct for the treatment for postpartum hemorrhage.
    Diop A; Abbas D; Ngoc NTN; Martin R; Razafi A; Tuyet HTD; Winikoff B
    Reprod Health; 2020 Mar; 17(1):34. PubMed ID: 32143721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.